Search images on Google Product Monograph
Active Ingredients:
- natalizumab, 300 MG/15 ML
DIN: 02286386
Dosage Form(s): SOLUTION
Route(s) of Administration: INTRAVENOUS
Schedule: Prescription
Company: BIOGEN CANADA INC
ATC:
- L04 - IMMUNOSUPPRESSANTS (ATC, WHO, Wiki)
- L04A - IMMUNOSUPPRESSANTS (ATC, WHO)
- L04AG - (ATC, WHO)
- L04AG03 - NATALIZUMAB (WHO)
Packaging:
- Package size unit: No information
- Package type: No information
- Package size: No information
- Product information: 1VIAL